Defiance Daily Target 2X Long ASTS ETF

ASTY · ETF

$2.14+$0.11 (+5.42%)TodayMarket closed ·
Prev close $2.03

About ASTY

ASTY was created on 2026-05-20 by Defiance. The fund's investment portfolio concentrates primarily on communication services equity. ASTY seeks to deliver 2x leveraged exposure to the daily share price movement of AST SpaceMobile, Inc. (NASDAQ: ASTS), less fees and expenses, through derivatives like options and swap agreements.

Issuer
Defiance
Expense ratio
1.31%
Assets under management
$5.76M
Inception
May 20, 2026
Asset class
Equity

ASTY key statistics

Price-earnings ratio
0.00
Average volume
278.01K
Volume
143.06K
Open price
$1.97
High today
$2.17
Low today
$1.83
52 Week high
$42.72
52 Week low
$1.94

Defiance Daily Target 2X Long ASTS ETF (ASTY) at a glance

Defiance Daily Target 2X Long ASTS ETF (ASTY) last traded at $2.14, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $1.83 and $2.17. The current price is 16.9% above the day's low and 1.4% below its high.

Volume so far is 143.06K shares, below the average of 278.01K shares a day.

Over the past year Defiance Daily Target 2X Long ASTS ETF has ranged from $1.94 to $42.72, and now sits 0% of the way up that range.

ASTY news

  • Chandrima Sanyal

    UFO ETF Hits $1 Billion In AUM As Wall Street Hunts For SpaceX Proxy Trades

  • Akanksha Bakshi

    AST SpaceMobile Jumps As Space Stocks Rally Before NASA Update

  • Chandrima Sanyal

    AST SpaceMobile Rally Gains Momentum With Defiance's New 2X Leveraged Fund

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.